Literature DB >> 23979756

Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.

Laura Judith Marcos-Zambrano1, Pilar Escribano, Cristina Rueda, Óscar Zaragoza, Emilio Bouza, Jesús Guinea.   

Abstract

We compared the ability of the EUCAST EDef 7.2 and the Etest to detect the susceptibility to micafungin of 160 Candida and non-Candida clinical isolates. Agreement was higher when Etest MICs were obtained after 24 h of incubation; essential agreement was 90%, and categorical agreement was >90%. False susceptibility was seen only for Candida krusei (10%), and false resistance was observed in 6% of the isolates, ranging from 2.6% (C. glabrata) to 13% (C. albicans).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23979756      PMCID： PMC3811256          DOI： 10.1128/AAC.01032-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

2.  EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).

Authors:  Maiken C Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William Hope
Journal:  Clin Microbiol Infect       Date:  2012-05-08       Impact factor: 8.067

3.  Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.

Authors:  M A Pfaller; M Castanheira; D J Diekema; S A Messer; G J Moet; R N Jones
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

4.  Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.

Authors:  J L Slater; S J Howard; A Sharp; J Goodwin; L M Gregson; A Alastruey-Izquierdo; M C Arendrup; P A Warn; D S Perlin; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

5.  Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.

Authors:  Marlene Axner-Elings; Silvia Botero-Kleiven; Rasmus Hare Jensen; Maiken Cavling Arendrup
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

6.  The presence of an FKS mutation rather than MIC is an independent risk factor for failure of echinocandin therapy among patients with invasive candidiasis due to Candida glabrata.

Authors:  Ryan K Shields; M Hong Nguyen; Ellen G Press; Andrea L Kwa; Shaoji Cheng; Chen Du; Cornelius J Clancy
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

7.  Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.

Authors:  Jesús Guinea; Teresa Peláez; Luis Alcalá; Emilio Bouza
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-02       Impact factor: 2.803

8.  Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.

Authors:  E Dannaoui; A Paugam; M Develoux; C Chochillon; J Matheron; A Datry; C Bouges-Michel; C Bonnal; F Dromer; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2009-09-23       Impact factor: 8.067

9.  Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients.

Authors:  J L Rodríguez-Tudela; J V Martínez-Suárez; F Dronda; F Laguna; F Chaves; E Valencia
Journal:  J Antimicrob Chemother       Date:  1995-06       Impact factor: 5.790

10.  Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.

Authors:  Erja Chryssanthou; Manuel Cuenca-Estrella
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948
View more
  10 in total

1.  In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.

Authors:  Jari Intra; Cecilia Sarto; Selene Mazzola; Chiara Fania; Natalia Tiberti; Paolo Brambilla
Journal:  Mycopathologia       Date:  2019-07-11       Impact factor: 2.574

2.  Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods.

Authors:  J Meletiadis; E Geertsen; I Curfs-Breuker; J F Meis; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

3.  Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.

Authors:  Laura Judith Marcos-Zambrano; Marta Gómez-Perosanz; Pilar Escribano; Oscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin.

Authors:  M-E Bougnoux; E Dannaoui; I Accoceberry; A Angoulvant; E Bailly; F Botterel; S Chevrier; T Chouaki; M Cornet; F Dalle; A Datry; A Dupuis; A Fekkar; J P Gangneux; J Guitard; C Hennequin; Y Le Govic; P Le Pape; D Maubon; S Ranque; M Sautour; B Sendid; J Chandenier
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Resistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture Samples.

Authors:  Pilar Escribano; Jesús Guinea; María Ángeles Bordallo-Cardona; Laura Judith Marcos-Zambrano; Carlos Sánchez-Carrillo; Emilio Bouza; Patricia Muñoz
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 6.  SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY.

Authors:  Ana Alastruey-Izquierdo; Marcia S C Melhem; Lucas X Bonfietti; Juan L Rodriguez-Tudela
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

7.  Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.

Authors:  Zahraa F Al-Baqsami; Suhail Ahmad; Ziauddin Khan
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

Review 8.  Antifungal Susceptibly Testing by Concentration Gradient Strip Etest Method for Fungal Isolates: A Review.

Authors:  Eric Dannaoui; Ana Espinel-Ingroff
Journal:  J Fungi (Basel)       Date:  2019-11-22

9.  Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine.

Authors:  Rodrigo Almeida-Paes; Maria Helena Galdino Figueiredo-Carvalho; Fábio Brito-Santos; Fernando Almeida-Silva; Manoel Marques Evangelista Oliveira; Rosely Maria Zancopé-Oliveira
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 10.  Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance.

Authors:  Ana Espinel-Ingroff
Journal:  J Fungi (Basel)       Date:  2022-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.